Tailoring CAR T cell technology for T cell leukemia

Mol Ther. 2023 Mar 1;31(3):603-604. doi: 10.1016/j.ymthe.2023.02.006. Epub 2023 Feb 16.

Authors

Christopher Schorr¹, Fabiana Perna²

Affiliations

¹ Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Biomedical Engineering, Purdue University Weldon School of Biomedical Engineering, West Lafayette, IN, United States.
² Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. Electronic address: [email protected].

No abstract available

Publication types

Editorial

MeSH terms

Antigens, CD19
Humans
Immunotherapy, Adoptive
Leukemia*
Leukemia, T-Cell*
Receptors, Chimeric Antigen* / genetics
T-Lymphocytes

Substances

Receptors, Chimeric Antigen
Antigens, CD19

Grants and funding

T32 GM077229/GM/NIGMS NIH HHS/United States